JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 51 filers reported holding JANUX THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $283 | -99.9% | 21,469 | -35.6% | 0.04% | -37.7% |
| Q3 2022 | $452,000 | +9.7% | 33,352 | -1.2% | 0.07% | -5.5% |
| Q2 2022 | $412,000 | +1.7% | 33,750 | +19.4% | 0.07% | +10.6% |
| Q1 2022 | $405,000 | -36.1% | 28,258 | -12.0% | 0.07% | -38.9% |
| Q4 2021 | $634,000 | +41.2% | 32,128 | +54.6% | 0.11% | +100.0% |
| Q3 2021 | $449,000 | – | 20,777 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 9,165,652 | $92,389,772 | 1.82% |
| BVF INC/IL | 4,579,818 | $46,164,565 | 1.24% |
| Samsara BioCapital, LLC | 360,414 | $3,632,973 | 1.11% |
| Orbimed Advisors | 3,317,927 | $33,444,704 | 0.71% |
| Old Well Partners, LLC | 10,300 | $103,824 | 0.09% |
| Corton Capital Inc. | 11,061 | $111,495 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,150,000 | $11,592,000 | 0.03% |
| XTX Topco Ltd | 13,636 | $137,451 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,067,468 | $20,823,593 | 0.01% |
| Alyeska Investment Group, L.P. | 175,000 | $1,764,000 | 0.01% |